期刊文献+

孕中期胎儿唐氏综合征筛查报道分析

Analysis and Report of Prenatal Screening for Down Syndrome in Midpregnancy Women
暂未订购
导出
摘要 目的初步分析孕妇血清标记物甲胎球蛋白和绒毛膜促性腺激素β亚基对胎儿唐氏综合征的产前筛查作用。方法采用时间分辨免疫荧光法,检测15~20周6d孕妇血清AFP和F-β-HCG浓度,结合孕妇年龄、孕周、体重,利用计算机软件,计算胎儿患唐氏综合征的风险率。结果筛查1614例孕妇,检出DS高危82例,占受检人数的5.1%;开放型神经管缺陷高危8例,占受检人数0.5%;18-三体高危2例,占受检人数0.1%;假阳性率为5%。结论检测孕中期孕母血清AFP和β-HCG两项指标进行产前筛查,对发现胎儿先天缺陷、预防唐氏综合征有重要作用。 Objective To investigate the effect of maternal serum markers AFP-HCG for prenatal screening of down syndrome. Methods Used a method based on detecting maternal serum alpha fetoprotein(AFP) and free beta-human chorionic gonadotrophin(F-β-HCG) concentrations in the women of 15-20 weeks and six days pregnanee in combination with maternal age and gestafional age and weight. Pregnant women at risk for fetal DS were identified by analyses of computer software. Results Among 1614 pregnant women, 82 cases (5.1% ) were at high risk for DS,8 cases(0.5%) were at high risk for NTD,2 cases(0.1%) were at high risk for 18-three body. Conclusion Prenatal screening by using of medium maternal serum markers AFP-HCG can provide sudstantial advantages for down syndrome.
出处 《中国现代医生》 2008年第29期20-21,共2页 China Modern Doctor
关键词 产前筛查 唐氏综合征 甲胎球蛋白 绒毛膜促性腺激素β亚基 Prenatal screening Down syndrome Alpha-fetoproteins Beta-human chorionic gonadotrophin
  • 相关文献

参考文献6

二级参考文献11

  • 1胡义刚,刘茂功,周凯,诸葛末伊,徐贵江.产前超声筛查胎儿畸形——附80例分析[J].中国妇幼保健,2005,20(24):3286-3287. 被引量:7
  • 2刘权章.人类染色体方法学[M].北京:人民卫生出版社,1992.269-271.
  • 3Wald N J, Kennard A, Hackshaw A et al. Antenatal screening for Down syndrome. J Med Screen, 1997, 4:181.
  • 4Merkatz IR, Nitowaky HM, Macri JN et al. An association between low maternal serum alpha- fetoprotein and fetal chromosomal abnormalities.Am J Obstet Gynecol, 1984, 148 : 886.
  • 5Saller DN, Canick JA. Maternal screening for fetal Down's syndrome: the detection of other pathologies. Clin Obstet Gynecol, 1996, 39(4) : 793.
  • 6Maymon R, Dreazen E, Weinraub Z et al. Screening for Down's syndrome at week 10 - 14 by measuring fetal nuchal translucency thickness. Harefuah, 1999, 137 (9) : 353.
  • 7Rozenberg P, Malagrida L, Cuckle H et al. Down's syndrome screening with nuchal translucency at 12 ( + 0) - 14 ( + 0) weeks and maternal serum markers at 14 ( + 1 ) -17 (+0) weeks: a prospective study.Hum Reprod, 2002, 17 (4) : 1093.
  • 8李光辉,黄醒华.孕妇血清标记物在产前诊断中的应用[J].中华妇产科杂志,1998,33(4):252-254. 被引量:40
  • 9鲍培忠.多种血清标记物在产前筛查中作用的综合评价[J].国外医学(计划生育分册),1999,18(2):74-78. 被引量:56
  • 10张迅.唐氏综合征的孕期筛查[J].中国实用妇科与产科杂志,2002,18(9):522-524. 被引量:39

共引文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部